Busulfan in hematopoietic stem cell transplant setting

Author： McCune Jeannine S   Holmberg Leona A  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.5, Iss.8, 2009-08, pp. : 957-969

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sexual health in hematopoietic stem cell transplant recipients

By  

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4124-4131

Blackwell Publishing

Access to resources Recommend Favorite

Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children

By  

Current Drug Metabolism, Vol. 15, Iss. 3, 2014-03 ,pp. : 251-264

Bentham Science Publishers

Access to resources Recommend Favorite

Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation

By Hassan Moustapha   Andersson Borje S  

Pharmacogenomics, Vol. 14, Iss. 1, 2013-01 ,pp. : 75-87

Future Medicine

Access to resources Recommend Favorite

Intravenous Busulfan: In the Conditioning Treatment of Pediatric Patients Prior to Hematopoietic Stem Cell Transplantation

By Hoy Sheridan M.   Lyseng-Williamson Katherine A.  

Pediatric Drugs, Vol. 9, Iss. 4, 2007-01 ,pp. : 271-278

Adis International

Access to resources Recommend Favorite

Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?

By Ansari Marc   Krajinovic Maja  

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1729-1732

Future Medicine

Access to resources Recommend Favorite